期刊文献+

NSE启动子调控的pNSE-IRES2-EGFP-p27双顺反子真核表达载体的构建及表达分析 被引量:1

Construction and Identification of a NSE-Promoter Regulatory Eukaryotic Bicistronic Expression Vector PNSE-IRES2-EGFP-p27
下载PDF
导出
摘要 目的:构建并鉴定带NSE启动子的Flag-p27和EGFP双顺反子真核表达载体pNSE-IRES2-EGFP-p27,转染原代培养的神经元,观察其表达。方法:通过质粒抽提,电泳、酶切、连接、转化等多种基因工程技术,经多步亚克隆后完成能同时表达p27和EGFP基因的神经元特异性表达载体pNSE-IRES2-EGFP-p27;转染体外培养的神经元观察EG-FP的表达及通过免疫荧光细胞化学技术观察p27的表达。结果:经酶切和测序鉴定,成功构建真核表达载体pNSE-IRES2-EGFP-p27;转染pNSE-IRES2-EGFP-p27后神经元中可见EGFP的表达,且EGFP阳性细胞中p27表达水平明显增高。结论:NSE启动子能启动目的基因p27和EGFP在神经元的表达,连于Flag-p27的下游EGFP可作为报告基因,指示p27的表达情况。带启动子NSE的Flag-p27和EGFP双顺反子真核表达载体的构建为进一步研究神经元细胞周期与神经系统疾病的关系,并为寻找神经系统疾病的有效基因治疗途径奠定基础。 Objective: To construct Flag-p27 and EGFP co-expressed pNSE-IRES2-EGFP-p27 plasmid, and to detect its expression in cultivated neurons. Methods: By way of genetic engineering techniques as plasmid extraction, agarose gel electrophoresis, restriction enzymolysis, connection, transformation of competent cells, the recombinant plasmid of pNSE-IRES2-EGFP-p27 was obtained. The constructed plasmids were transfected to cultivated neurons with liposome and the expression of EGFP and p27 was detected by immunocytochemistry. Results: pNSE-IRES2-EGFP-p27 was successfully constructed and verified by enzymolysis and sequencing. Confocal microscopy revealed that after the plasmids were transfected to neurons, the expression of EGFP could be detected and the expression of p27 was increased significantly in EGFP positive cells. Conclusion:The vectors containing the NSE promoter resulted in the EGFP and p27 expression in neurons. EGFP can be as a report gene to indicate the expression of p27. The construction of pNSE-IRES2-EGFP- p27 lies a foundation for future research on the relationship between cell cycle of neurons and nervous system disease.
出处 《中国康复》 2007年第6期382-385,共4页 Chinese Journal of Rehabilitation
基金 国家自然科学基金重点项目(30230140)
关键词 启动子 构建 靶向性 真核表达载体 bicistron neuron eukaryotic expression vector cell cycle
  • 相关文献

参考文献16

  • 1NAGY Z, ESIRI MM, SMITH AD. The Cell Division Cycle and the Pathophysiology of Alzheimer's Disease[J]. Neuroscience(S0306-4522), 1998,87 (4):731- 739.
  • 2ARENDT T, HOI.ZER M, GARTNER U, et al. Abet rancies in Signal Transduction and Cell Cycle Related E vents in Alzheimer's Disease[J]. J Neural Transm Suppl (S0300-9564), 1998,54:147- 158.
  • 3NAGY Z. Cell cycle Regulatory Failure in Neurones: Causes and Consequences[J]. Neurobiol Aging(S0197- 4580), 2000,21(6) :761-769.
  • 4GIOVANNI A, WIRTZ-BRUGGER F, KERAMAR1S E, et al. Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F x DP, in B-amyloid induced Neuronal Death[J]. J Biol Chem(S0021-9258), 1999,274(27) : 19011- 19016.
  • 5COPANI A, CONDORELLI F, CARUSO A, et al. Mitotic Signaling by Beta-myloid Causes Neuronal Death[J]. FASEB J(S0892-6638), 1999, 13:225-234.
  • 6TAKASHIMA A, MURAYAMA M, YASUTAKE K, et al. Involvement of Cyclin Dependent Kinase5 Activator p25 on tau Phosphorylation in Mouse Brain[J]. Neurosci Lett (S0304-3940), 2001,306(1-2) :37-40.
  • 7ZHANG ZG, BOWER L, ZHANG RL et al. Three Di mensional Measurement of Cerebral Micro-vascular Plasma Perfusion, Glial Fibrillary Acidic Protein and Micro-tubule Associated Protein 2 Immunoreactivity after Em bolic Stroke in Rats.. A Double Fluorescent Labeled Laser-scanning Confocal Microscope Study[J]. Brain Res (S0006-8993), 1999, 844: 55-68.
  • 8BELLETTI B, NICOLOSO et al. P27(kipl ) Functional MS, SCHIAPPACASSI M, Regulation in Human Cancer: A Potential Target for Therapeutic Designs[J]. Curr Med Chem(S0929-8673),2005,12(14) :1589-1605.
  • 9KATCHANOV J, HARMS C, GERTZ K, et al. Mild Cerebral Ischemia Induces Loss of Cyclin-dependent Kinase Inhibitors and Activation of Cell Cycle Machinery before Delayed Neuronal Cell Death[J]. J Neurosci (S0270-6474),2001,21(14) :5045-5053.
  • 10杨美兰,朱遂强,陈辉,阮旭中.海马神经元活化产物对大鼠GABA(α_1)受体表达的影响[J].中国康复,2004,19(4):195-197. 被引量:3

二级参考文献9

  • 1Huang RQ, Bell-Horner CL, Dibas MI, et al. Pentylenetetrazole-Induced Inhibition of Recombinant γ-Aminobutyric Acid Type A (GABAA) Receptors: Mechanism and Site of Action[J]. J Pharmacology Exp Ther, 2001, 298(3): 986-995.
  • 2Fathaolabi Y, Motamedi F, Semanian S, et al. Examination of persistent effects of repeated administration of pentylentetrazol on rat hippocampal CA1: evidence from in vitro study on hippocampal slices[J]. Brain Res, 1997,758(1-2): 92-98.
  • 3Albensi BC, Mattson MP. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity[J]. Synapse, 2000, 35(2): 151-159.
  • 4Savolainen KM, Loikkanen J, Eerikainen S, et al. Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead[J]. Toxicol Lett, 1998, 28(102-103): 363-367.
  • 5Blondeau N, Widmann C, Lazdunski M,et al. Activation of the nuclear factor-kappaB is a key event in brain tolerance[J]. J Neurosci, 2001,21(13): 4668-4677.
  • 6Karle J. Antisense studies of brain GABAA receptors[J]. Dan Med Bull, 2002,49(2): 130-144.
  • 7Shehab S, Coffey P, Dean P, et al. Regional expression of fos-like immunoreactivity following seizures induced by pentylenetetrazole and maximal electroshock[J]. Exp Neurology, 1992,118(3): 261-274.
  • 8Fisher RS. Animal models of the epilepsies[J]. Brain Res Rev ,1989,14(3): 245-278.
  • 9朱长庚.神经-免疫-内分泌网络与癫痫发病机理的关系[J].解剖学报,2002,33(3):321-324. 被引量:79

共引文献2

同被引文献16

  • 1潘惠妮,吴郁丽,张成,梁小兵.神经元特异性烯醇化酶与新生儿缺氧缺血性脑病及脑性瘫痪的相关性[J].中国临床康复,2006,10(18):97-100. 被引量:10
  • 2Moore BW, McGregor D. Chromatographic and electropho- retic fractionation of soluble proteins of brain and liver [J]. J Biol Chem, 1965, 240: 1647-1653.
  • 3Levy YS, Merms D, Panet H, et al. Induction of neuron- specific enolase promoter and neuronal markers in differen- tiated mouse bone marrows stromal cells [J]. J Mol Neurosci, 2003, 21(2): 121-132.
  • 4Bohmer AE, Oses AP, Paneuger M, et al. Neuron-specific enolase, s-100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury [J]. Neurosurgery, 2011, 68(6): 1624-1651.
  • 5Chabok SY, Moghadam AD, Saneei Z, et al. Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury [J]. Trauma Acute Care Surg, 2012, 72(6): 1654-1657.
  • 6Sun J, Li J, Cheng G, et al. Effects of hypothermia on NSE and S-100 protein levels in CSF in neonates following hy- poxic/ischaemic brain damage [J]. Acta Paediatr, 2012, 101 (8): e316-320.
  • 7Newcomb JK, Zhao X, Pike BR, et al. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat [J]. Exp Neurol, 1999, 158(1): 76-88.
  • 8Marargos PJ, Schmechel D, Parma AM, et al. Measurement of neuron-specific enolase(NSE)and non-neuronal enolase (NNE) isoenzymes of enolase in rat, monkey, and human nervous tissue [J]. J Nenrochem, 1979, 33(1): 319-329.
  • 9朱余德,袁伯稳,周辉,季风华.惊厥患儿血清神经元特异性烯醇化酶的变化及其临床意义[J].苏州大学学报(医学版),2007,27(4):619-620. 被引量:5
  • 10卢庆晖,彭爱霞,阳红华.脑脊液神经元特异性烯醇化酶对高胆红素血症新生儿远期神经发育的预测价值[J].实用儿科临床杂志,2007,22(24):1867-1868. 被引量:3

引证文献1

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部